Current Neuro-Oncology

Volume 24 Number 14
31 July 2022

Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 14, 31 July

Hagiwara A, Schlossman J, Shabani S, Raymond C, Tatekawa H, Abrey LE, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Cloughesy TF, Ellingson BM.
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.
J Neurooncol. 2022 Jul 17
. doi: 10.1007/s11060-022-04088-3. PMID: 35842871. Observational study˰ ˍ

Thakur S, Kumar N, Salunke P, Ahuja C, Madan R.
A Randomized Study of Short Course (One Week) Radiation Therapy with or without Temozolomide in Elderly and/or Frail Patients with Newly Diagnosed Glioblastoma (GBM).
Asian Pac J Cancer Prev. 2022 Jul 17, 2022;23(7):2317-2323. doi: 10.31557/APJCP.2022.23.7.2317. PMID: 35901337. Interventional study. ˍ

Mizuno R, Homma T, Adachi JI, Mishima K, Suzuki T, Shirahata M, Nishikawa R, Atushi S.
True anaplastic oligoastrocytoma with dual genotype: illustrative case.
J Neurosurg Case Lessons. 2022 Jul 18, 2022;4(3):CASE22146
. doi: 10.3171/CASE22146. PMID: 36046704. Case report. ˍ

Kline C, Jain P, Kilburn L, Bonner ER, Gupta N, Crawford JR, Banerjee A, Packer RJ, Villanueva-Meyer J, Luks T, Zhang Y, Kambhampati M, Zhang J, Yadavilli S, Zhang B, Gaonkar KS, Rokita JL, Kraya A, Kuhn J, Liang W, Byron S, Berens M, Molinaro A, Prados M, Resnick A, Waszak SM, Nazarian J, Mueller S.
Upfront biology-guided therapy in diffuse intrinsic pontine glioma: therapeutic, molecular, and biomarker outcomes from PNOC003.
Clin Cancer Res. 2022 Jul 19, 2022:CCR-22-0803
. doi: 10.1158/1078-0432.CCR-22-0803. PMID: 35852795. Interventional study. ˍ


Raschke F, Witzmann K, Seidlitz A, Wesemann T, Jentsch C, Platzek I, van den Hoff J, Kotzerke J, Beuthien-Baumann B, Baumann M, Linn J, Krause M, Troost EGC.
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy.
Clin Transl Radiat Oncol. 2022 Jul 20, 2022;36:99-105
. doi: 10.1016/j.ctro.2022.07.003. PMID: 35965663. Observational study. ˍ

Yogendran LV, Kalelioglu T, Donahue JH, Ahmad H, Phillips KA, Calautti NM, Lopes MB, Asthagiri AR, Purow B, Schiff D, Patel SH, Fadul CE.
The landscape of brain tumor mimics in neuro-oncology practice.
J Neurooncol. 2022 Jul 20
. doi: 10.1007/s11060-022-04087-4. PMID: 35857249. Observational study˰ ˍ

Lin Z, Yang R, Zheng H, Li Z, Yi G, Wu Q, Yang C, Huang G.
Pleomorphic xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and epithelioid glioblastoma: Case series with clinical characteristics, molecular features and progression relationship.
Clin Neurol Neurosurg. 2022 Jul 21, 2022;221:107379
. doi: 10.1016/j.clineuro.2022.107379. PMID: 35932588. Observational study. ˍ

Luger AL, König S, Samp PF, Urban H, Divé I, Burger MC, Voss M, Franz K, Fokas E, Filipski K, Demes MC, Stenzinger A, Sahm F, Reuss DE, Harter PN, Wagner S, Hattingen E, Wichert J, Lapa C, Fröhling S, Steinbach JP, Ronellenfitsch MW.
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.
J Neurooncol. 2022 Jul 21
. doi: 10.1007/s11060-022-04049-w. PMID: 35864412. Observational study. ˍ

Ohno M, Miyakita Y, Takahashi M, Yanagisawa S, Tamura Y, Narita Y.
Continuing maintenance temozolomide therapy beyond 12 cycles confers no clinical benefit over discontinuation at 12 cycles in patients with IDH1/2-wildtype glioblastoma.
Jpn J Clin Oncol. 2022 Jul 21, 2022:hyac114
. doi: 10.1093/jjco/hyac114. PMID: 35858227. Observational study˰ ˍ

Todo T, Ino Y, Ohtsu H, Shibahara J, Tanaka M.
A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma.
Nat Commun. 2022 Jul 21, 2022;13(1):4119
. doi: 10.1038/s41467-022-31262-y. PMID: 35864115. Interventional study. ˍ


Todo T, Ito H, Ino Y, Ohtsu H, Ota Y, Shibahara J, Tanaka M.
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.
Nat Med. 2022 Jul 21
. doi: 10.1038/s41591-022-01897-x. PMID: 35864254. Interventional study. ˍ

Voisin MR, Zuccato JA, Wang JZ, Zadeh G.
Surgery for recurrent GBM: a retrospective case-control study.
World Neurosurg. 2022 Jul 21, 2022:S1878-8750(22)01019-1
. doi: 10.1016/j.wneu.2022.07.070. PMID: 35870781. Observational study˰ ˍ

Elserius ASL, Hodson J, Zisakis A, Ughratdar I.
Is there a limited value of cytoreductive surgery in elderly patients with malignant gliomas?
Surg Neurol Int. 2022 Jul 22, 2022;13:320
. doi: 10.25259/SNI_438_2022. PMID: 35928314. Observational study. ˍ

Lombardi F, Augello FR, Artone S, Ayroldi E, Giusti I, Dolo V, Cifone MG, Cinque B, Palumbo P.
Cyclooxygenase-2 Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In Extracellular Vesicles Modifying Recipient Cell Phenotype.
Front Oncol. 2022 Jul 22, 2022;12:933746
. doi: 10.3389/fonc.2022.933746. PMID: 35936755. Laboratory investigation. ˍ

Muir M, Traylor JI, Gadot R, Patel R, Prabhu SS.
Repeat laser interstitial thermal therapy for recurrent primary and metastatic intracranial tumors.
Surg Neurol Int. 2022 Jul 22, 2022;13:311
. doi: 10.25259/SNI_418_2022. PMID: 35928321. Observational study. ˍ

Kamble AN, Agrawal NK, Koundal S, Bhargava S, Kamble AN, Joyner DA, Kalelioglu T, Patel SH, Jain R.
Imaging-based stratification of adult gliomas prognosticates survival and correlates with the 2021 WHO classification.
Neuroradiology. 2022 Jul 25
. doi: 10.1007/s00234-022-03015-7. PMID: 35876874. Observational study˰ ˍ

Pant I, Chaturvedi S, S Gautam VK, Sarma P, Satti DK.
Extra-axial adult cerebellopontine angle medulloblastoma: Revisiting a rare entity.
J Cancer Res Ther. 2022 Jul 25, 2022;18(3):770-773
. doi: 10.4103/jcrt.JCRT_675_20. PMID: 35900553. Case report. ˍ

Schepke E, Löfgren M, Pietsch T, Bontell TO, Kling T, Wenger A, Vega SF, Danielsson A, Dosa S, Holm S, Öberg A, Nyman P, Eliasson-Hofvander M, Sandström PE, Pfister SM, Lannering B, Sabel M, Carén H.
DNA methylation profiling improves routine diagnosis of paediatric CNS tumours: a prospective population-based study.
Neuropathol Appl Neurobiol. 2022 Jul 26, 2022:e12838
. doi: 10.1111/nan.12838. PMID: 35892159. Observational study˰ ˍ

Steininger K, Kahl KH, Konietzko I, Wolfert C, Motov S, Krauß PE, Bröcheler T, Hadrawa M, Sommer B, Stüben G, Shiban E.
Intraoperative radiotherapy during awake craniotomies: preliminary results of a single-center case series.
Neurosurg Rev. 2022 Jul 26
. doi: 10.1007/s10143-022-01838-9. PMID: 35881316. Observational study. ˍ

Chen J, Qiu H, Chen R, Huang J, Chen L, Wan J, Chen Q, Zhang L.
Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma.
Comput Math Methods Med. 2022 Jul 27, 2022;2022:9547166
. doi: 10.1155/2022/9547166. PMID: 35936378. Observational study. ˍ

Chen J, Kang Z, Li S, Wang C, Zheng X, Cai Z, Pan L, Chen F, Li W.
Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes.
Front Immunol. 2022 Jul 28, 2022;13:911260
. doi: 10.3389/fimmu.2022.911260. PMID: 35967388. Laboratory investigation. ˍ


Lin K, Gueble SE, Sundaram RK, Huseman ED, Bindra RS, Herzon SB.
Mechanism-based design of agents that selectively target drug-resistant glioma.
Science. 2022 Jul 28, 2022;377(6605):502-511
. doi: 10.1126/science.abn7570. PMID: 35901163. Laboratory investigation. ˍ

Gao S, Jin L, Moliterno J, Corbin ZA, Bindra RS, Contessa JN, Yu JB, Park HS.
Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma.
J Neurosurg. 2022 Jul 29, 2022:1-11
. doi: 10.3171/2022.5.JNS212761. PMID: 35907197. Observational study˰ ˍ


Goldman S, Margol A, Hwang EI, Tanaka K, Suchorska B, Crawford JR, Kesari S.
Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data.
Front Oncol. 2022 Jul 29, 2022;12:958637
. doi: 10.3389/fonc.2022.958637. PMID: 36072789. Observational study. ˍ

Guan Y, Pan M, Yang J, Lu Q, Han L, Liu Y, Li J, Zhu H, Gong X, Mei G, Liu X, Pan L, Dai J, Wang Y, Wang E, Wang X.
A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol.
BMC Cancer. 2022 Jul 29, 2022;22(1):827
. doi: 10.1186/s12885-022-09914-5. PMID: 35906549. Interventional study. ˍ

Hassel B, Niehusmann P, Halvorsen B, Dahlberg D.
Pro-inflammatory cytokines in cystic glioblastoma: A quantitative study with a comparison with bacterial brain abscesses. With an MRI investigation of displacement and destruction of the brain tissue surrounding a glioblastoma.
Front Oncol. 2022 Jul 29, 2022;12:846674
. doi: 10.3389/fonc.2022.846674. PMID: 35965529. Laboratory investigation. ˍ


He X, Zhao W, Huang J, Xu J, Niu S, Zhang Q, Zhang N, Jin H, Shen G.
Characteristics and trends of globally registered glioma clinical trials in the past 16 years.
Ther Adv Neurol Disord. 2022 Jul 29
;15:112. doi: 10.1177/17562864221114355. PMID: 35923217. Observational study. ˍ

Stoltze UK, Foss-Skiftesvik J, van Overeem Hansen T, Byrjalsen A, Sehested A, Scheie D, Mikkelsen TS, Rasmussen S, Bak M, Okkels H, Callesen MT, Skjøth-Rasmussen J, Gerdes AM, Schmiegelow K, Mathiasen R, Wadt K.
Genetic predisposition & evolutionary traces of pediatric cancer risk: A prospective 5-year population-based genome sequencing study of children with CNS tumors.
Neuro Oncol. 2022 Jul 29, 2022:noac187
. doi: 10.1093/neuonc/noac187. PMID: 35902210. Interventional study˰ ˍ

Kim SM, Lim EJ, Yoo KC, Zhao Y, Kang JH, Lim EJ, Shin I, Kang SG, Lim HW, Lee SJ.
Glioblastoma-educated mesenchymal stem-like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment.
Clin Transl Med. 2022 Jul 31, 2022;12(8):e997
. doi: 10.1002/ctm2.997. PMID: 35908277. Laboratory investigation. ˍ


Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wißmann N, Botz M, Soyka SJ, Beretta CA, Pramatarov RL, Fankhauser L, Garofano L, Freudenberg A, Wagner J, Tanev DI, Ratliff M, Xie R, Kessler T, Hoffmann DC, Hai L, Dörflinger Y, Hoppe S, Yabo YA, Golebiewska A, Niclou SP, Sahm F, Lasorella A, Slowik M, Döring L, Iavarone A, Wick W, Kuner T, Winkler F.
Glioblastoma hijacks neuronal mechanisms for brain invasion.
Cell. 2022 Jul 31, 2022;185(16):2899-2917.e31
. doi: 10.1016/j.cell.2022.06.054. PMID: 35914528. Laboratory investigation˰ ˍ